Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation: Sobi’s Q3 2023 report

Sobi plans to publish its report for the third quarter of 2023 on 30 October 2023 at 08:00 CET.Investors, analysts, and media are invited to participate in a conference call which will include a presentation of the results and a Q&A session on the same day at 13:00 pm CET, 12:00 pm GMT, and 8:00 am EDT.   The presentation can be followed live here  or afterwards on sobi.com . The slides will be made available on sobi.com before the conference call.   To participate in the conference

Nel ASA: Invitation to Q3 2023 results presentation

(October 18, 2023 – Oslo, Norway) Nel ASA (Nel, OSE:NEL) will publish its third quarter 2023 report on 25 October 2023 at 07:00 CET, and host a presentation at 08:00 CET. The quarterly report and presentation will be made available on www.newsweb.no and www.nelhydrogen.com. The presentation at 08:00 CET will be a virtual event, followed by a Q&A session. The live presentation can be accessed on the company’s website nelhydrogen.com/quarterly-presentation/ or by following this link 

BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING ON 18 OCTOBER 2023 IN RIGHTBRIDGE VENTURES GROUP AB

The Extraordinary General Meeting of Rightbridge Ventures Group AB, reg. no. 559058-5807, (the "Company"), was held today, 18 October 2023, at Eversheds Sutherland Advokatbyrå's premises at Sveavägen 20 in Stockholm.The following main resolutions were passed with the required majority at the meeting:   Election of new members of the Board of Directors and election of Chairman of the Board of Directors   It was resolved to elect Kin-Wai Lau, Mads Jørgensen and Carl Falkenberg as new members of the Board of Directors. Mads Jørgensen was elected Chairman of the Board. As Board

Annual Financial Report

Fidelity Emerging Markets Limited Annual Report and Accounts Following the release by Fidelity Emerging Markets Limited (the "Company") on 13 October 2023 of the Company's Full Year Results Announcement for the year ended 30 June 2023, the Company announces that it has published the 2023 Annual Report and Accounts. The document is available to view on the Company's website and, in accordance with Listing Rule 9.6.1, a copy has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

Insider information, profit warning: Ponsse cuts its guidance for 2023

Ponsse Plc, Insider information, October 18, 2023 at 3:20 p.m. (EEST) Ponsse cuts its guidance for 2023. The company’s euro-denominated operating profit in 2023 is expected to be on a par with the operating profit of its continuing operations in 2022 (EUR 46.6 million).New guidance for 2023The company’s euro-denominated operating profit in 2023 is expected to be on a par with the operating profit of its continuing operations in 2022 (EUR 46.6 million).  Reasons for the new guidancePersistent inflation has continued to impact the profitability of the business. As we enter a

Wihlborgs’ interim report for Jan-Sept 2023 will be presented on 24 October – invitation to presentation

On Tuesday 24 October 2023, at 7:30 a.m. (CEST), Wihlborgs’ interim report for January-September 2023 will be published. Wihlborgs invites press, investors and analysts to a webcast and telephone conference at 9:00 a.m. (CEST) on the same date.During the webcast and telephone conference, Ulrika Hallengren, CEO of Wihlborgs, and Arvid Liepe, CFO, will present Wihlborgs’ interim report for January-September 2023. Following the presentation, there will be the opportunity to pose questions. The presentation will be held in English.  Date:                  24 OctoberTime:

Hufvudstaden wins Swedish customer satisfaction award with highest rating ever

Hufvudstaden has cemented its first place on the list of large property companies in Sweden’s annual Fastighetsbarometer customer survey of office tenants. Hufvudstaden has increased its top rating from the previous year by two places, giving it a customer satisfaction rating of 88. This is the sixth consecutive year that Hufvudstaden has been ranked top in the survey.“Once again, I’d like to express our sincere thanks to all our customers who, by participating in the survey, help us to continuously develop and improve our offering. This year, Hufvudstaden improved in several categories,

BE Group interim report January – September 2023

Third quarter · Net sales decreased by 22% to SEK 1,187 M (1,514) · The underlying operating result amounted to SEK 4 M (67) · The operating result amounted to SEK -42 M (40), including inventory losses of SEK -40 M (-27) and items affecting comparability of SEK -6 M (-) due to restructuring · Result after tax amounted to SEK -42 M (26) · Cash flow from operating activities amounted to SEK -17 M (-183) · Earnings per share amounted to SEK -3.27 (2.05) Statement from the CEOMarket conditions remained difficult, particularly in the construction sector, causing net

Mölnlycke[®] wins prestigious award for making a positive impact on society and addressing global challenges

· Mölnlycke[®] Health Care has been awarded the 2023 Enlightened Growth Leadership Award by The Frost & Sullivan Institute for commitment to creating a positive impact on society and striving towards a sustainable future  · The Frost & Sullivan Institute Award celebrates visionary companies that have harmonised growth with global stewardshipGothenburg, Sweden. 18 October 2023: Mölnlycke Health Care, a world-leading MedTech company, has been awarded the prestigious Enlightened Growth Leadership Award by the Frost & Sullivan Institute for its dedication and leadership in its commitment to

Quickbit publishes prospectus in connection with the rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE ILLEGAL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER ACTION.  The Board of Directors of Quickbit eu AB (publ) (Nasdaq First North Growth Market: QUICK) ("Quickbit" or the "Company") announced on August 15, 2023, with the support of the authorization from the Annual General Meeting on November 22,

Demolition project of Metsä Fibre’s old Kemi pulp mill starts

Metsä Fibre press release 18.10.2023Metsä Fibre, part of Metsä Group, closed down the old pulp mill in Kemi with the start-up of the new Kemi bioproduct mill. The securitisation and preparation for dismantling of the old mill started immediately after the shutdown. The actual demolition will start in early 2024 and the project will run until 2025. "In the first phase, the old mill will be made safe so that the dismantling process is not dangerous and the work goes as smoothly as possible," says Erkka Tahvanainen, VP Production Development , Metsä Fibre, who is responsible for the

BioGaia AB’s Nomination Committee for the 2024 Annual General Meeting

BioGaia AB’s Nomination Committee for the Annual General Meeting 2024 has been appointed based on the ownership structure as of June 30, 2023.The Nomination Committee consists of: Peter Rothschild, Chair of the Board BioGaia AB Per-Erik Andersson, Annwall & Rothschild Investments AB Jacob Sellman, EQT Marianne Flink, AP4 Russell Champion, Premier Miton InvestorsShareholders who would like to submit proposals to the Nomination Committee can do so by e-mail to nominationcommittee@biogaia.com or by ordinary mail under the address BioGaia AB, Nomination Committee, Kungsbroplan

BioStock: Annexin’s CSO on progress in cancer initiative

One of Annexin Pharmaceuticals’ important achievements lately is having created a conjugate of the drug candidate ANXV. By binding the candidate to a chemotherapy agent, the goal is to eventually offer a cancer treatment with a new mechanism of action where effective treatments are currently lacking. BioStock contacted the company’s CSO/CMO and co-founder Anna Frostegård to know more about the importance and the plans going forward.Read the interview with Annexin Pharmaceuticals' CSO/CMO and co-founder Anna Frostegård here: https://www.biostock.se/en/2023/10/annexins-cso-on-progress-in-

Correction: ChromoGenics discloses order intake for the third quarter 2023

ChromoGenics AB submits this correction as the previous announcemnet today was missding the MAR label. The message should have included the following text: This information constitutes such information that ChromoGenics AB (publ) is obligated to disclose in accordance with the EU Market Abuse Regulation. The information was submitted by the above-mentioned contact persons for publication on 18th October, at 11:20 CET.ChromoGenic's order intake for the third quarter of 2023 amounts to SEK 8.3 million, a considerably higher level than the previous quarter. "It is very gratifying that the

ChromoGenics discloses order intake for the third quarter 2023

ChromoGenic's order intake for the third quarter of 2023 amounts to SEK 8.3 million, a considerably higher level than the previous quarter. "It is very gratifying that the order intake now is progressing. We have seen a good growth in inquiries for some time, both from Sweden and European markets. We have booked a number of smaller projects during the quarter as well as one larger. As the order intake is significantly higher than previous quarters, we have chosen to communicate this figure before the quarterly report is released on 23 November" says Fredrik Fränding, CEO. The product,

Invitation to OKEA third quarter 2023 conference call

(Trondheim, 18 October 2023) OKEA ASA (OSE: OKEA) OKEA will publish its financial report for the third quarter of 2023 on Thursday 26 October at 06.00 CET. A trading update summarizing key figures for the quarter will be published on 19 October at 08.00 CET.A presentation of the results will be held on 26 October through a webcast and audioconference starting 10:00 CET. The presentation will be held by Svein J. Liknes (CEO) and Birte Norheim (CFO).The webcast can be followed at www.okea.noor OKEA Webcast Q3 2023 (royalcast.com) 

Søren Pedersen appointed Head of Winter Maintenance

Klimator, a leading provider of innovative solutions for combating road ice during the winter season, is pleased to announce the appointment of Sören Pedersen as Head of Winter Maintenance at Klimator. With his extensive history within the company and substantial experience in the field, Søren is a natural successor to Emil Danielsson, who became the CEO of Klimator in May.Sören Pedersen, currently responsible for Klimator's operations in Denmark, where the development of IoT sensors has been central, now assumes responsibility for the entire Winter Maintenance business area. Sören is

Invitation to presentation of Embellence Group’s interim report for the third quarter 2023

Embellence Group publishes the quarterly report for the third quarter 2023 on October 25 at 08:00 CEST. In connection with the announcement, Embellence Group invites to a conference call on the same day, held at 10:00 CEST.The presentation will be held in English by Olle Svensk (CEO) and Karin Lidén (CFO). If you wish to participate via webcast please use the link below. Via the webcast you are able to ask written questions.https://ir.financialhearings.com/embellence-group-q3-report-2023 If you wish to participate via teleconference please register on the link below. After

Raisio publishes January-September 2023 Interim Report on 1 November 2023

Raisio plc, Press Release 18 October 2023 Raisio plc will publish its Interim Report for January-September 2023 on Wednesday, 1 November 2023, approximately at 8.30 am EET. The report will be available at www.raisio.com after publication. Webcast targeted for analysts, investors and media will be held in Finnish by CEO Pekka Kuusniemi on the same day, starting at 12.00 EET. Webcast will be available on this link: https://raisio.videosync.fi/q3-2023. Recording of the Finnish webcast will be available on the same link. After the webcast, English presentation slide-deck will be

Invitation to presentation and Q&A of interim report July-September 2023

On the 25th of October, at 9:30 CET, Sleep Cycle will present the interim report for July-September 2023 for shareholders, media and other stakeholders. Participants will be able to follow the presentation via webcast.Sleep Cycles acting CEO and CFO Per Andersson will present the report, which will be followed by a Q&A session. The presentation will be held in English. Link to webcast: https://ir.financialhearings.com/sleep-cycle-q3-2023 If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a

Appointments to lead the ongoing feasibility study in the Americas

Outokumpu Oyj Press releaseOctober 18, 2023 at 11.00 am EEST Micheal Tecza, Stefan Erdmann, Hugh Embrey Appointments to lead the ongoing feasibility study in the Americas Outokumpu announced on August 3 that the company has conducted a feasibility study to explore options to increase its existing cold-rolling capacity and investigate different options for its hot-rolling arrangements in Calvert, Alabama. Outokumpu has now appointed two key people to drive the program further. Michael Tecza has been appointed as Project Director. He is joining from Intel and has an

Readly partners with Arla LactoFREE

Readly, Europe’s leading digital magazine and newspaper subscription service, has partnered with Arla LactoFREE, to offer customers a free subscription to its digital reading app. The UK wide partnership involves Readly offering its broad portfolio of titles to nutrition and health-engaged consumers, enabling them to read over 7,500 digital magazines and newspapers. Readly and Arla LactoFREE are offering consumers the opportunity to claim a free 2 month Readly subscription when they buy any promotional pack of LactoFREE 1 litre milk.   “The collaboration with Arla

Getinge solutions enable Fujirebio to speed up antibody production

The partnership between Getinge and Fujirebio is all about creating value. The latest progress comes from a new pre-validated wash rack, enabling the staff at Fujirebio to create a standardized cleaning process of multi-use bioreactors which saves time in their important work to produce more antibodies used in cancer diagnostics. Since founded in Japan 1950, the multinational biotech company Fujirebio is specialized in cancer diagnostics. Its Swedish hub is located in top modern laboratories at GoCo Health Innovation City – a growing innovation cluster for health and life science

There are no items matching the current filter
There are no more items matching the current filter
Back to top